載入...
Management of imatinib-resistant patients with chronic myeloid leukemia
Since its approval in 2001 for frontline management of chronic myelogenous leukemia (CML), imatinib has proven to be very effective in achieving high remission rates and improving prognosis. However, up to 33% of patients will not achieve optimal response. This has led researchers to develop new sec...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3629755/ https://ncbi.nlm.nih.gov/pubmed/23610618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620712468289 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|